Literature DB >> 10587545

Autocrine induction of gliostatin/platelet-derived endothelial cell growth factor (GLS/PD-ECGF) and GLS-induced expression of matrix metalloproteinases in rheumatoid arthritis synoviocytes.

H Muro1, Y Waguri-Nagaya, Y Mukofujiwara, T Iwahashi, T Otsuka, N Matsui, A Moriyama, K Asai, T Kato.   

Abstract

OBJECTIVE: The purpose of this study was to examine how gliostatin/platelet-derived endothelial cell growth factor (GLS/PD-ECGF) is involved in the molecular mechanism of cartilage degradation in rheumatoid arthritis (RA) with special reference to the GLS-induced gene expression and protein synthesis of matrix metalloproteinase (MMP)-1 (collagenase-1) and MMP-3 (stromelysin-1).
METHODS: Fibroblast-like synoviocytes (FLSs) obtained from RA patients were cultured and stimulated by GLS. Changes in the expression levels of GLS, MMP-1 and MMP-3 were assessed by Northern blot analysis and reverse transcription-polymerase chain reaction (RT-PCR) for GLS, and by RT-PCR and enzyme-linked immunosorbent assay for MMPs and tissue inhibitor of metalloproteinase 1.
RESULTS: GLS demonstrated a self-induction of mRNA in cultured RA FLSs. GLS evoked a dose-dependent induction of MMP-1 and MMP-3 mRNAs, and subsequently their extracellular secretion.
CONCLUSION: These findings suggest that GLS is a plausible pathogenic factor causing the extensive joint destruction in RA mediated via MMPs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10587545     DOI: 10.1093/rheumatology/38.12.1195

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  7 in total

1.  The inhibitory effect of disease-modifying anti-rheumatic drugs and steroids on gliostatin/platelet-derived endothelial cell growth factor production in human fibroblast-like synoviocytes.

Authors:  Takuma Kusabe; Yuko Waguri-Nagaya; Tomohiro Tanikawa; Mineyoshi Aoyama; Muneyoshi Fukuoka; Masaaki Kobayashi; Takanobu Otsuka; Kiyofumi Asai
Journal:  Rheumatol Int       Date:  2005-07-01       Impact factor: 2.631

2.  FK506 inhibition of gliostatin/thymidine phosphorylase production induced by tumor necrosis factor-α in rheumatoid fibroblast-like synoviocytes.

Authors:  Takaya Yamagami; Yuko Waguri-Nagaya; Kenji Ikuta; Mineyoshi Aoyama; Kiyofumi Asai; Takanobu Otsuka
Journal:  Rheumatol Int       Date:  2010-03-18       Impact factor: 2.631

3.  Gliostatin/thymidine phosphorylase-regulated vascular endothelial growth-factor production in human fibroblast-like synoviocytes.

Authors:  Tomohiro Tanikawa; Yuko Waguri-Nagaya; Takuma Kusabe; Mineyoshi Aoyama; Kiyofumi Asai; Takanobu Otsuka
Journal:  Rheumatol Int       Date:  2006-11-14       Impact factor: 2.631

4.  Thrombin inhibits aquaporin 4 expression through protein kinase C-dependent pathway in cultured astrocytes.

Authors:  Yuping Tang; Dingfang Cai; Yiping Chen
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

5.  The Sp1 transcription factor is essential for the expression of gliostatin/thymidine phosphorylase in rheumatoid fibroblast-like synoviocytes.

Authors:  Kenji Ikuta; Yuko Waguri-Nagaya; Kae Kikuchi; Takaya Yamagami; Masahiro Nozaki; Mineyoshi Aoyama; Kiyofumi Asai; Takanobu Otsuka
Journal:  Arthritis Res Ther       Date:  2012-04-25       Impact factor: 5.156

Review 6.  The dual role of thymidine phosphorylase in cancer development and chemotherapy.

Authors:  Annelies Bronckaers; Federico Gago; Jan Balzarini; Sandra Liekens
Journal:  Med Res Rev       Date:  2009-11       Impact factor: 12.944

7.  The Janus kinase inhibitor (baricitinib) suppresses the rheumatoid arthritis active marker gliostatin/thymidine phosphorylase in human fibroblast-like synoviocytes.

Authors:  Yuji Joyo; Yohei Kawaguchi; Hiroki Yonezu; Hiroya Senda; Sanshiro Yasuma; Hiroo Shiraga; Masahiro Nozaki; Mineyoshi Aoyama; Kiyofumi Asai; Hideki Murakami; Yuko Waguri-Nagaya
Journal:  Immunol Res       Date:  2022-01-10       Impact factor: 2.829

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.